Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma

Maria J. De Herdt(Erasmus MC Cancer Institute), Leendert H. J. Looijenga(Princess Máxima Center)
Oncotarget
February 20, 2016
Cited by 17


Related Papers